NeoStem, Inc. Announces Research Supporting VSEL(TM) Technology Presented at the American Society of Hematology Annual Meeting

Published: Jan 09, 2013

NEW YORK, Jan. 9, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS), an emerging leader in the fast growing cell therapy market, announced today that multiple abstracts presented December 8-11 at the 2012 American Society of Hematology ("ASH") annual meeting, add to the growing body of scientific work describing the capabilities of very small embryonic-like stem cells ("VSELsā„¢"). These papers are published as 2012 Annual Meeting Abstracts in the journal Blood, Volume 120, Issue 21.

Back to news